SLT Holdings
VRTX icon

SLT Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

SLT Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$253K Sell
483
-20
-4% -$10.2K 0.15% 120
2026
Q2 		$250K Buy
503
+20
+4% +$8.86K 0.15% 126
2026
Q1 		$216K Buy
+483
New +$225K 0.15% 121

Other funds holding VRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

SLT Holdings's VRTX Position: Q3 2026 in Review

SLT Holdings reduced its Vertex Pharmaceuticals (VRTX) stake by 4% in Q3 2026, selling an estimated $10.2K and leaving 483 shares worth $253K. The position accounts for 0.15% of the portfolio, ranked #120.

SLT Holdings first reported a position in VRTX in Q1 2026 and has held it in 3 quarters since. 992 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • SLT Holdings held 483 shares of Vertex Pharmaceuticals worth $253K as of Q3 2026.
  • SLT Holdings sold 20 Vertex Pharmaceuticals shares in Q3 2026, an estimated $10.2K.
  • Vertex Pharmaceuticals made up 0.15% of SLT Holdings's portfolio in Q3 2026, its #120 holding.
  • SLT Holdings first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 992 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on SLT Holdings's 13F filing for Q3 2026, filed 15 Oct 2026.